Search

It’s six years since Europe led the way and created a regulatory framework for approving generic versions of biopharmaceuticals, or biosimilars. Now similar legislation has been enacted in the US

A more flexible grant system will generate more innovation and create more value than the current Framework Programme 7’s €6.1B health research budget

The funders of the telescope have established a founding board and selected Jodrell Bank Observatory, Manchester, UK to host the project office

Disagreement on allowing products from the offspring of cloned animals onto the market in Europe has left plans to update all regulations on novel foods in tatters

With a strong pipeline of drugs in development, a good flow of venture capital investment and seven IPOs, 2010 was an “exceptional” year, says France Biotech

It’s still more than a year to go until the next Euroscience meeting in Dublin in 2012, but Copenhagen has been announced as the venue for the event in 2014